Legal & General Group Plc - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 86 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is 15.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q1 2022$5,000
-50.0%
1,8150.0%0.00%
Q4 2021$10,000
-81.5%
1,815
-71.9%
0.00%
Q3 2021$54,000
+100.0%
6,468
+194.1%
0.00%
Q2 2021$27,000
-62.5%
2,199
-26.3%
0.00%
Q1 2021$72,000
-11.1%
2,985
+17.6%
0.00%
Q4 2020$81,000
+5.2%
2,5390.0%0.00%
Q3 2020$77,000
-23.0%
2,539
+7.0%
0.00%
Q2 2020$100,000
+122.2%
2,374
+27.0%
0.00%
Q1 2020$45,0001,8700.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q1 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 634,191$1,820,1282.14%
NEA Management Company, LLC 4,448,757$12,767,9330.99%
CHI Advisors LLC 720,000$2,066,4000.82%
Bellevue Group AG 8,135,839$23,349,8580.38%
Parkman Healthcare Partners LLC 520,587$1,494,0850.27%
Artal Group S.A. 2,046,517$5,8740.25%
RA Capital Management 3,525,754$10,118,9140.20%
Ikarian Capital, LLC 555,572$1,594,4920.19%
TANG CAPITAL MANAGEMENT LLC 400,000$1,148,0000.16%
Newtyn Management, LLC 205,000$588,3500.14%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders